{"pub_date": "2016-11-04T19:27:29Z", "subsection_name": "DealBook", "lead_paragraph": "Prosecutors are investigating drug makers for colluding over prices, but higher consumer costs may be a natural consequence of reduced competition.", "print_page": null, "document_type": "article", "byline": {"person": [{"rank": 1, "organization": "", "lastname": "CYRAN", "firstname": "Robert", "role": "reported"}], "original": "By ROBERT CYRAN"}, "multimedia": [], "section_name": "Business Day", "headline": {"content_kicker": "Breakingviews", "main": "Competition Would Be the Best Solution to Rising Drug Prices", "kicker": "Breakingviews"}, "source": "The New York Times", "blog": [], "word_count": "393", "web_url": "http://www.nytimes.com/2016/11/05/business/dealbook/competition-would-be-the-best-solution-to-rising-drug-prices.html", "slideshow_credits": null, "news_desk": "Business", "type_of_material": "News", "snippet": "Prosecutors are investigating drug makers for colluding over prices, but higher consumer costs may be a natural consequence of reduced competition....", "_id": "581ce12c7c459f6a5fccc51a", "abstract": null, "keywords": [{"rank": "1", "name": "subject", "value": "Antitrust Laws and Competition Issues", "is_major": "N"}, {"rank": "2", "name": "organizations", "value": "Food and Drug Administration", "is_major": "N"}, {"rank": "3", "name": "subject", "value": "Drugs (Pharmaceuticals)", "is_major": "N"}]}